Though Pfizer Inc.’s work on a PD-1-targeting antibody has trailed far behind that of its fellow big pharmas, the company could be the first to market in treatment-naïve, high-risk non-muscle invasive ...

Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...

A new U.K. study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) ...

If you’ve ever had a urinary tract infection (UTI,) you understand that the thing you want the most is for the burning, ...

Most important note is- surgeries for benign enlargement removes only the center part of the prostate to clear the ...

Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder ...

Learn how food safety and dietary choices impact urinary tract infections, with tips on prevention and reducing risks for ...